Cargando…
In-Hospital Glycemic Dysregulation Associated With Worse Outcomes in COVID-19
Introduction: Evidence establishes that COVID-19 patients with DM2 are at increased risk for severe disease and worse outcomes. Peer reviewed data is sparse comparing glycemic control and clinical outcomes among COVID-19 patients with vs. without DM2, and thus we sought to address this gap. Methods:...
Autores principales: | Rodriguez, Lisette Patricia, Farhangi, Vida, Braham, Julaine, Smith, Robert A, Wiese-Rometsch, Wilhelmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089908/ http://dx.doi.org/10.1210/jendso/bvab048.705 |
Ejemplares similares
-
Alpelisib-Induced Diabetic Ketoacidosis- A Case Report
por: Rodriguez, Lisette Patricia, et al.
Publicado: (2021) -
THU331 Glycemic Variability In Critically Ill Sepsis Patients Comorbid With COVID-19: Relative Impact Of Diabetes And/Or Obesity
por: June Rebernigg, Janevi, et al.
Publicado: (2023) -
PSUN146 Diabetes, Obesity, and Diabetes-Obesity Overlap Syndrome in Hospitalized Adult COVID-19 Patients: Comorbidity Dose is The Thing!
por: Rodriguez, Karla Baez, et al.
Publicado: (2022) -
THU332 Composite Glucose And Albumin Biomarker Tool Provides Strong Mortality Risk Assessment At Presentation And Throughout Index COVID-19 Hospitalization
por: Torres Rivera, Nicole, et al.
Publicado: (2023) -
THU318 Endocrine Phenotype Drives Mortality Risk At Presentation During Index Hospitalization With SARS-CoV-2 Infection: Differential Trait Signatures May Shed Some Light
por: Baez, Karla, et al.
Publicado: (2023)